What is the best cutoff value of PSA in detection of prostate cancer

被引：0

作者：

Gemalmaz, Hakan ^{[1
]}

机构：

[1] Adnan Menderes Univ, Tip Fak, Urol Anabilim Dali, Aydin, Turkey

来源：

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY | 2012年 / 11卷 / 02期

关键词：

Prostate Cancer; PSA; biopsy;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

While a PSA threshold of 4ng/ml has traditionally been accepted as the level at which to recommend prostate biopsy, deciding whom to biopsy has become even more complicated with the results of Prostate Cancer Prevention Trial (PCPT). This study showed that prostate cancer exists at all PSA levels instead of a certain cut-off level of PSA. It has always been important for an urologist to decide to get biopsy from a patient regarding the patients PSA level and age, and to avoid over-treatment. In this review, the results of the remarkable studies published up to date have been explained and how our daily clinical practice is shaped according to these studies is described.

引用

页码：92 / 95

页数：4

共 50 条

[41] Low psa levels cannot rule out prostate cancer:: Prostate cancer detection rates with respect to psa levels
Horninger, W.
Klocker, H.
Bektic, J.
Pelzer, A. E.
Schafer, G.
Achleitner, R.
Bartsch, G.
EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 277 - 277
[42] PROGNOSTIC VALUE OF THE PERCENTAGE OF FREE PSA IN THE LOCALIZED PROSTATE CANCER
Filella, X.
Alcover, J.
Molina, R.
Auge, J. M.
Corral, J.
Escudero, J. M.
TUMOR BIOLOGY, 2010, 31 : S117 - S117
[43] VALUE OF LONGITUDINAL PERCENT FREE PSA IN PROSTATE CANCER DIAGNOSIS
Benecchi, Luigi
Potenzoni, Michele
Pastizzaro, Carmelo Destro
Uliano, Nicoletta
Pieri, Anna Maria
JOURNAL OF UROLOGY, 2011, 185 (04): : E809 - E809
[44] WHAT ARE THE BEST CUT-POINTS FOR PSA DOUBLING TIME IN MEN WITH NON-METASTATIC CASTRATIONRESISTANT PROSTATE CANCER?
Howard, Lauren
Moreira, Daniel
De Hoedt, Amanda
Aronson, William
Kane, Christopher
Amling, Christopher
Cooperberg, Matthew
Terris, Martha
Freedland, Stephen
JOURNAL OF UROLOGY, 2017, 197 (04): : E246 - E247
[45] Prostate cancer and prostate specific antigen (PSA) levels:: What is the PSA limit which reflects the prostate cancer itself and not the amount of benign tissue anymore?
Zlotta, AR
Djavan, B
Ravery, V
Shoeibi, H
Ekane, S
Hoffman, P
Fourmarier, M
Roumeguère, T
Bollens, R
Petein, M
Marberger, M
Schulman, CC
JOURNAL OF UROLOGY, 2003, 169 (04): : 276 - 276
[46] Diagnostic value of a SUVmax cutoff in predicting clinically significant prostate cancer?
Nassour, Anthony-Joe
Jain, Anika
Hui, Nicholas
Symons, James
Woo, Henry
INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 : 20 - 20
[47] PSA cutoff point of 2.5ng/ml reveals significantly curable prostate cancer
Saito, Seiichi
JOURNAL OF UROLOGY, 2008, 179 (04): : 603 - 604
[48] PSA testing, cancer treatment, and prostate cancer mortality reduction: What is the mechanism?
Albertsen, Peter C.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (02) : 78 - 81
[49] Value of PSA (prostate-specific antigen) in the detection of prostate cancer in patients with urological symptoms. Results of a multicentre study
Filella, X
Molina, R
Ballesta, AM
Gil, MJ
Allepuz, C
Rioja, LA
Perez, B
Esquerda, A
Guajardo, J
Zulueta, ML
Flores, N
Gallego, J
Genolla, J
Aranburu, I
Arruza, A
Corominas, A
Pastor, MC
Comet, J
Enguidanos, MJ
Jimenez, J
Ortiz, B
Casanova, J
Solsona, E
Palazon, J
Salas, A
Ballesteros, JJ
Vidriales, I
Larrodera, ML
Leyva, O
Garcia, C
Gonzalez, M
Ortiz, J
Marcos, ML
Carballido, J
Casero, C
Alonso, A
Chicharro, JA
Milena, A
Gonzalez, C
Concepcion, T
Salcedo, E
Sebastian, JL
Blanco, N
Canadas, E
Cozar, JM
Silva, C
Cruz, M
Camacho, E
EUROPEAN JOURNAL OF CANCER, 1996, 32A (07) : 1125 - 1128
[50] Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
F. Strittmatter
P. Stieber
D. Nagel
C. Füllhase
S. Walther
C. G. Stief
R. Waidelich
European Journal of Medical Research, 16

← 1 2 3 4 5 →